ClinicalTrials.gg
Enrolling by invitationNCT06101979Updated Jul 25, 2025

A Prospective Study of Fortiva in Hernia Repair

An observational study in Ventral Hernia, Incisional Hernia and Abdominal Wall Reconstruction, sponsored by RTI Surgical. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-25.

Sponsored by RTI Surgical · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to evaluate safety and performance of the Fortiva Tissue Matrix. Participants will complete questionnaires to measure outcomes after hernia surgery for two years.

Read the detailed description

This is a post market, prospective, multi-center study of up to 120 participants at approximately 10 clinical study sites. Safety and performance will be measured after hernia repair for two years.

02

Conditions studied

  • Ventral Hernia
  • Incisional Hernia
  • Abdominal Wall Reconstruction
03

In context

Hernia, Ventral

230 studies on the registry are indexed under Hernia, Ventral; 45 are open to participants now.

This study's planned enrollment of 120 is close to the median of 132 across 65 observational studies indexed under Hernia, Ventral.

Browse Hernia, Ventral studies →

Lead sponsor

RTI Surgical is the lead sponsor of 16 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be candidates for hernia surgery recruited from the participating Investigator's population

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age at time of consent
  • Undergoing hernia surgery in which Fortiva Tissue Matrix will be used
  • Have no to the test material (s)
  • Able to provide
  • Able to read, understand and complete study questionnaires
  • Able and willing to return for scheduled study visits

Exclusion criteria

Exclusion Criteria:

  • \<18 years of age
  • (ASA) physical class of 4,5 or 6
  • Currently enrolled or plans to enroll in another clinical study that would affect the validity of the study
  • Hernia repairs involving active infection
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Fortiva Tissue Matrix

    Device: Fortiva Tissue Matrix

Interventions

  • DeviceFortiva Tissue Matrix

    Acellular Dermal Matrix used in hernia surgery

06

What researchers measure

Primary outcomes

  1. Type of adverse events

    Time frame: 6 weeks, 6 months, 12 months and 24 months

Secondary outcomes

  1. Patient satisfaction

    SF-36 questionnaire has 8 multi-item scales with a higher score representing better health status. Each domain has a score range of 0-100

    Time frame: 6 weeks, 6 months, 12 months and 24 months

  2. Pain measured using the visual analog scale for pain

    Visual Analog Scale using a scale of 0-10 with 0 being no pain and 10 being unbearable pain

    Time frame: 6 weeks, 6 months, 12 months and 24 months

  3. Implant failure

    Partial or total removal of Fortiva Tissue Matrix

    Time frame: 6 weeks, 6 months, 12 months and 24 months

  4. Hernia recurrence

    Hernia recurrence requiring surgical reintervention

    Time frame: 12 months

07

Study locations

1 site
  • James Paget University Hospital
    Great Yarmouth, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06101979
Lead sponsor
RTI Surgical
Responsible party
Sponsor
First posted
Oct 26, 2023
Start date
Nov 15, 2023
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jul 25, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion